A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study
- Janet S. Rader
- , Michael W. Sill
- , Jan H. Beumer
- , Heather A. Lankes
- , Doris Mangiaracina Benbrook
- , Francisco Garcia
- , Connie Trimble
- , J. Tate Thigpen
- , Richard Lieberman
- , Rosemary E. Zuna
- , Charles A. Leath
- , Nick M. Spirtos
- , John Byron
- , Premal H. Thaker
- , Shashikant Lele
- , David Alberts
Research output: Contribution to journal › Article › peer-review
21
Link opens in a new tab
Scopus
citations